Regulations/Legal

Latest Issue of OR Manager
April 2021
Home Regulations/Legal

Joint Commission offers Advanced Certification for Spine Surgery

Editor's Note The Joint Commission on February 24 announced that it will be offering an Advanced Certification for Spine Surgery (ACSS) in collaboration with the American Academy of Orthopaedic Surgeons (AAOS). The new program will be available in July to hospitals, critical access hospitals, and ambulatory surgery centers that perform…

Read More

By: Judy Mathias
February 25, 2021
Share

Joint Commission updates information on offsite surveys, reviews

Editor's Note The Joint Commission, on February 17, announced that it had updated its information on offsite (ie, virtual) surveys and reviews. In response to COVID-19, the Joint Commission stopped most onsite surveys and reviews from March 16 to May 31, 2020, and they developed processes for offsite events. As…

Read More

By: Judy Mathias
February 18, 2021
Share

More states report telehealth reimbursement laws

Editor's Note A Foley & Lardner survey finds that state telehealth reimbursement laws have significantly increased during the COVID-10 pandemic, but more can be done to address telehealth adoption barriers, the February 15 Revcycle Intelligence reports. More than 43 states and Washington, DC, have some telehealth statute for commercial payers,…

Read More

By: Judy Mathias
February 18, 2021
Share

Sponsored Message

Support programs multiply as pandemic strains health systems

Burnout among healthcare workers was on the rise long before 2020, but it has skyrocketed during the COVID-19 pandemic. As a result, many healthcare organizations have stepped up efforts to support their staffs. “Maybe 20% of burnout is something an individual can control, but the other 80% is the work…

Read More

By: Elizabeth Wood
February 17, 2021
Share

Joint Commission conducting both virtual and onsite surveys in 2021

The Joint Commission stopped doing most onsite surveys and reviews from March 16 to May 31, 2020, in response to the COVID-19 pandemic. During that time, they developed processes for conducting offsite or virtual events, and as of mid-December, more than 1,200 offsite surveys and reviews had been conducted across…

Read More

By: Judith M. Mathias, MA, RN
February 17, 2021
Share

Diligence in implant processing will decrease infection risks

Implants are foreign bodies, and they increase the risk of a surgical site infection. Processing implants requires strict adherence to the required steps because implants have sustained contact with sterile tissue. An implant is defined as a device that is placed into a surgically or naturally formed cavity of the…

Read More

By: Susan Klacik, BS, CRCST, ACE, CIS, FCS
February 17, 2021
Share

Sponsored Message

Reports of anaphylaxis after Pfizer, Moderna vaccines

Editor's Note Since emergency use authorization of the Pfizer-BioNTech and Moderna vaccines in December, the Centers for Disease Control and Prevention’s Vaccine Adverse Event Reporting System (VAERS) has received reports of allergic reactions including anaphylaxis. From December 14, 2020, through January 18, 2021, 9,943,247 doses of the Pfizer vaccine and…

Read More

By: Judy Mathias
February 16, 2021
Share

CDC updates guidelines on school reopenings

Editor's Note The Centers for Disease Control and Prevention (CDC) on February 12 updated its guidelines for K-12 school reopenings. The update provides an operational strategy for safe delivery of in-person instruction through the integration of mitigation and control components as well as public health efforts. Included are the following:…

Read More

By: Judy Mathias
February 16, 2021
Share

Joint Commission issues new Quick Safety on safe, equitable care during COVID-19

Editor's Note The Joint Commission, on February 8, issued a new Quick Safety addressing safe, equitable care during the COVID-19 pandemic. The Quick Safety focuses on actions organizations can take to: address racial and ethnic disparities remove barriers to providing safe, equitable healthcare. The pandemic has put a spotlight on…

Read More

By: Judy Mathias
February 11, 2021
Share

FDA issues EUA for monoclonal antibody treatments for COVID-19

Editor's Note The Food & Drug Administration, on February 9, issued an emergency use authorization (EUA) for Eli Lilly’s (Indianapolis, Indiana) combination therapy of two antibodies, bamlanivimab and etesevimab. The authorization is for the two antibodies to be administered together for treatment of mild to moderate COVID-19 in adults and…

Read More

By: Judy Mathias
February 11, 2021
Share

Get OR Manager Updates

Sign Up Now
Video Spotlight
 
OR Manager Jobs
Live chat by BoldChat